Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025

Read more

Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets

Read more

Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData

Read more

Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData

Read more

Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU

Read more

Biocon Biologics’ Ustekinumab Biosimilar receives positive CHMP opinion

Read more

Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector

Read more

Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio

Read more

Glenmark launches Lacosamide Oral Solution, bioequivalent to Vimpat

Read more

Rusan Pharma achieves key GMP approvals for Australian and Brazilian markets

Read more